Skip to main content

Table 4 Top interacting drug with its pharmacological known and predicted protein target

From: In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Drug name IUPAC name Drug structure Known pharmacological target Predicted drug target
Pimozide 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one Dopamine D2 receptor [53] AChE
Bromperidol 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one Dopamine D2 receptor [54] BuChE
Melperone 1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one Dopamine D2/D3 and 5-HT2A antagonist [55] MAO A
Anisoperidone 1-(4-methoxyphenyl)-4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butan-1-one Dopamine D2 and 5-HT2A receptors [56] BACE 1 (3L5E)
Benperidol 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one  Dopamine D2 antagonist [57] BACE 1 (4D8C)
Anisopirol 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-ol Dopamine receptor [58] NMDA